Q BioMed Inc.
QBIO
$0.00
$0.000.00%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Net Income | -485.00K | -2.05M | -6.42M | -7.42M | -8.05M |
| Total Depreciation and Amortization | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K |
| Total Amortization of Deferred Charges | 766.40K | 922.60K | 1.14M | 1.04M | 720.20K |
| Total Other Non-Cash Items | 406.90K | 1.27M | 1.48M | 1.92M | 2.09M |
| Change in Net Operating Assets | 1.44M | 1.75M | 1.47M | 1.52M | 1.33M |
| Cash from Operations | 2.18M | 1.94M | -2.29M | -2.89M | -3.86M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.14M | -3.14M | -- | -- | -- |
| Cash from Investing | -3.14M | -3.14M | -- | -- | -- |
| Total Debt Issued | 764.10K | 652.70K | 2.10M | 2.48M | 2.51M |
| Total Debt Repaid | -- | -- | 0.00 | -30.00K | -30.00K |
| Issuance of Common Stock | 0.00 | 100.00K | 100.00K | 100.00K | 1.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.00K | 155.00K | 70.00K | 70.00K | 70.00K |
| Cash from Financing | 849.10K | 907.70K | 2.27M | 2.62M | 3.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -267.20K | -- | -- | -- | -- |
| Net Change in Cash | -381.20K | -294.00K | -13.30K | -263.20K | -297.90K |